Dexlansoprazole Capsule, Delayed Release
Product Images NDC 50090-7451

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dexlansoprazole (NDC 50090-7451). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Dexlansoprazole Delayed Release Capsules 1)

FDA Label Image

Figure 1 (Dexlansoprazole Delayed Release Capsules 2)

Figure 1 (Dexlansoprazole Delayed Release Capsules 2)
This text provides a comparison of plasma concentrations of dexlansoprazole at 30 mg and 60 mg doses. The graph shows the increase in plasma concentration of dexlansoprazole with the higher dose.*
FDA Label Image

Label Image (Lbl500907451)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.